Home › Companies › Nuvation Bio Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Nuvation Bio Inc.’s Form 8-K, filed 2026-05-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore Nuvation Bio Inc. in the interactive database Compare manager voting policies
These tallies are Nuvation Bio Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Robert B. Bazemore, Jr. | 197,674,280 | -- | -- | 37,655,082 | 55,602,434 | Majority: yes |
| Elect Director: Robert Mashal, M.D. | 216,772,840 | -- | -- | 18,556,522 | 55,602,434 | Majority: yes |
| Proposal 2: Ratification of Independent Registered Public Accounting Firm. The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | 290,273,104 | 413,176 | 245,516 | -- | 0 | Majority: yes |
| Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers | 230,050,644 | 4,950,024 | 328,694 | -- | 55,602,434 | Majority: yes |
Source: Nuvation Bio Inc., Form 8-K, filed with the SEC on 2026-05-27 — read the filing on EDGAR.
Each item below shows how the 194 asset managers that disclosed a Nuvation Bio Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Nuvation Bio Inc.’s own tally for this item (“Proposal 3: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. The Company's stockholders approved, on an advisory basis, the compensation of”): 230,050,644 for, 4,950,024 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 346,503,675 outstanding shares: 66% for, 1% against (68% of the company cast a for/against vote).
The 192 asset managers below cast 97% of the shares they voted on this item FOR (186,291,119 for, 6,086,717 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 75,803,361 | 0 | 0 | 0 | For |
| Decheng Capital LLC | 25,954,439 | 0 | 0 | 0 | For |
| Vanguard | 15,660,181 | 4 | 0 | 0 | For |
| BlackRock | 13,902,273 | 41,646 | 0 | 0 | For |
| Omega Fund Management, LLC | 8,081,089 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 7,768,289 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,844,498 | 0 | 0 | 0 | For |
| American Century | 0 | 4,608,577 | 0 | 0 | Against |
| Charles Schwab | 3,930,161 | 0 | 0 | 0 | For |
| State Street | 3,157,208 | 6,283 | 0 | 0 | For |
| Redmile Group, LLC | 3,153,256 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 2,628,226 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,592,995 | 0 | 0 | 0 | For |
| Northern Trust | 1,287,612 | 19,057 | 0 | 0 | For |
| ABRAMS CAPITAL MANAGEMENT, L.P. | 1,270,504 | 0 | 0 | 0 | For |
| Nuveen | 1,233,825 | 0 | 0 | 0 | For |
| TIAA | 1,186,668 | 0 | 0 | 0 | For |
| SEI | 898,148 | 0 | 0 | 0 | For |
| Two Sigma | 894,763 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 664,788 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 638,185 | 0 | 0 | 0 | For |
| Beacon Pointe Advisors, LLC | 585,051 | 0 | 0 | 0 | For |
| Invesco | 0 | 523,528 | 0 | 0 | Against |
| Palo Alto Investors LP | 508,846 | 0 | 0 | 0 | For |
| Equitable | 496,032 | 0 | 0 | 0 | For |
Showing the 25 largest of 192 asset managers. See all 192 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Nuvation Bio Inc.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm. The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal yea”): 290,273,104 for, 413,176 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 346,503,675 outstanding shares: 84% for, 0.2% against (84% of the company cast a for/against vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (61,334,163 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 28,699,358 | 0 | 0 | 0 | For |
| Vanguard | 13,711,193 | 0 | 0 | 0 | For |
| BlackRock | 7,249,158 | 0 | 0 | 0 | For |
| American Century | 2,196,254 | 0 | 0 | 0 | For |
| Charles Schwab | 1,963,390 | 0 | 0 | 0 | For |
| TIAA | 1,186,668 | 0 | 0 | 0 | For |
| State Street | 611,868 | 0 | 0 | 0 | For |
| Equitable | 496,032 | 0 | 0 | 0 | For |
| TANAKA FUNDS INC | 485,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 446,082 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 394,982 | 0 | 0 | 0 | For |
| Tema ETF Trust | 390,195 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 375,087 | 0 | 0 | 0 | For |
| SEI | 340,055 | 0 | 0 | 0 | For |
| Dimensional | 298,894 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 287,737 | 0 | 0 | 0 | For |
| Lincoln Financial | 282,091 | 0 | 0 | 0 | For |
| Invesco | 196,672 | 0 | 0 | 0 | For |
| Brighthouse | 150,127 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 147,221 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 135,730 | 0 | 0 | 0 | For |
| Northern Trust | 119,420 | 0 | 0 | 0 | For |
| Global X | 112,780 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 103,158 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 95,161 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 6 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Nuvation Bio Inc.’s own tally for this item (“Elect Director: Robert B. Bazemore, Jr.”): 197,674,280 for, 37,655,082 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 346,503,675 outstanding shares: 57% for, 11% withheld (68% of the company cast a for/withheld vote).
The 54 asset managers below cast 100% of the shares they voted on this item FOR (47,594,110 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 23,708,791 | 0 | 4,990,567 | 0 | For |
| Vanguard | 13,681,217 | 0 | 29,976 | 0 | For |
| BlackRock | 7,249,158 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 2,196,254 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,963,390 | 0 | Abstain |
| TIAA | 0 | 0 | 1,186,668 | 0 | Abstain |
| State Street | 573 | 0 | 611,295 | 0 | Abstain |
| Equitable | 347,452 | 0 | 148,580 | 0 | For |
| TANAKA FUNDS INC | 485,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 446,082 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 394,982 | 0 | Abstain |
| Tema ETF Trust | 390,195 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 375,087 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 340,055 | 0 | Abstain |
| Dimensional | 0 | 0 | 298,894 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 287,737 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 282,091 | 0 | Abstain |
| Invesco | 196,672 | 0 | 0 | 0 | For |
| Brighthouse | 77,574 | 0 | 72,553 | 0 | For |
| BUFFALO FUNDS | 147,221 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 0 | 0 | 135,730 | 0 | Abstain |
| Northern Trust | 0 | 0 | 119,420 | 0 | Abstain |
| Global X | 0 | 0 | 112,780 | 0 | Abstain |
| Bridge Builder Trust | 103,158 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 95,161 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 6 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Nuvation Bio Inc.’s own tally for this item (“Elect Director: Robert Mashal, M.D.”): 216,772,840 for, 18,556,522 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 346,503,675 outstanding shares: 63% for, 5% withheld (68% of the company cast a for/withheld vote).
The 54 asset managers below cast 100% of the shares they voted on this item FOR (56,141,835 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 28,699,358 | 0 | 0 | 0 | For |
| Vanguard | 13,711,164 | 0 | 29 | 0 | For |
| BlackRock | 7,249,158 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 2,196,254 | 0 | Abstain |
| Charles Schwab | 1,963,390 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 1,186,668 | 0 | Abstain |
| State Street | 611,366 | 0 | 502 | 0 | For |
| Equitable | 347,452 | 0 | 148,580 | 0 | For |
| TANAKA FUNDS INC | 485,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 446,082 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 394,982 | 0 | Abstain |
| Tema ETF Trust | 390,195 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 375,087 | 0 | 0 | 0 | For |
| SEI | 340,055 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 298,894 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 287,737 | 0 | Abstain |
| Lincoln Financial | 164,600 | 0 | 117,491 | 0 | For |
| Invesco | 196,672 | 0 | 0 | 0 | For |
| Brighthouse | 77,574 | 0 | 72,553 | 0 | For |
| BUFFALO FUNDS | 147,221 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 135,730 | 0 | 0 | 0 | For |
| Northern Trust | 119,420 | 0 | 0 | 0 | For |
| Global X | 112,780 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 103,158 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 95,161 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Ranked by the number of Nuvation Bio Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 346,503,675 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 21.88% |
| 2 | Decheng Capital LLC | 7.49% |
| 3 | Vanguard | 4.52% |
| 4 | BlackRock | 4.02% |
| 5 | Omega Fund Management, LLC | 2.33% |
| 6 | Laurion Capital Management LP | 2.24% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.69% |
| 8 | American Century | 1.33% |
| 9 | Charles Schwab | 1.13% |
| 10 | State Street | 0.91% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| David Hung, M.D. | 17.11% | DEF14A |
| FMR (Fidelity) | 15.00% | 13F |
| Entities affiliated with FMR LLC | 14.60% | DEF14A |
| Entities affiliated with Decheng Anbio Limited | 7.49% | DEF14A |
| Min Cui, Ph.D. | 7.49% | DEF14A |
| BlackRock | 7.24% | 13F |
| Vanguard Group | 4.49% | 13F |
| State Street | 1.96% | 13F |
| Geode Capital | 1.69% | 13F |
| Two Sigma | 0.77% | 13F |
Percentages above are of 346,503,675 shares outstanding, as reported by Nuvation Bio Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Nuvation Bio Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Nuvation Bio Inc.'s shareholder meeting held 2026-05-21, in the 2025-2026 proxy season, 194 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 970 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Nuvation Bio Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-27.
Nuvation Bio Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).